New perspectives in the drug therapy of hormone-resistant prostate cancer
Vorob'ev, N.A.; Nosov, A.K.; Vorob'ev, A.V.; Moiseenko, V.M.
Voprosy Onkologii 56(6): 645-653
2010
ISSN/ISBN: 0507-3758 PMID: 21395118 Document Number: 645398
Document emailed within 1 workday
Related Documents
Gibbons, R.P. 1989: Management of hormone-resistant prostate cancer Progress in Clinical and Biological Research 303: 337-345Roznovanu, S.L.ăc.ăm.; Amălinci, C.; Rădulescu, D.ţa. 2005: Molecular mechanisms in hormone-resistant prostate cancer Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 109(3): 577-583
Miyake, H.; Fujisawa, M. 2014: Antisense oligodeoxynucleotide therapy for castration-resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2121-2125
Arai, Y.; Ogawa, O. 2019: Hormone Therapy and Castration Resistance of Prostate Cancer Canadian Journal of Urology 26(2): 9686
Zaruba, A.I.; Kutsenko, A.I.; Kukharchuk, V.V.; Masenko, V.P. 1989: Effect of isolated ultrafiltration on plasma hormone levels in patients with heart failure resistant to drug therapy Kardiologiia 29(9): 46-49
Hu, Y.-H.; Guo, J.-C.; Zhang, M. 2017: Bipolar androgen therapy: a novel therapeutic strategy for castration-resistant prostate cancer Zhonghua Nan Ke Xue 23(12): 1138-1140
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Miglietta, L.; Cannobbio, L.; Boccardo, F. 1995: Assessment of response to carboplatin in patients with hormone-refractory prostate cancer: a critical analysis of drug activity Anticancer Research 15(6b): 2825-2828
Nicol, D.L.; Heathcote, P.S.; Kateley, G.D.; Lloyd, S. 1993: Advanced prostate cancer. the role of high priced hormone therapy Medical Journal of Australia 159(1): 16-19
Alvarez Rodríguez, S.; Alonso Gordoa, T.; Burgos Revilla, F.Javier. 2018: Current status of androgen deprivation therapy in hormone-sensitive prostate cancer Archivos Espanoles de Urologia 71(3): 247-257
Ying, J.; Yao, D.-H.; Ren, X.-M. 2003: Study of sexual hormone changes in prostate cancer patients before and after androgen deprivation therapy Zhonghua Nan Ke Xue 9(3): 191-192; 196
Gumenetskaya, Y.V.; Mardynsky, Y.S.; Karyakin, O.B.; Gulidov, I.A.; Biryukov, V.A. 2015: An experience with dose-escalated conformal radiation therapy in hormone-radiotherapy for prostate cancer Voprosy Onkologii 61(1): 57-61
St-Arnaud, R.; Lachance, R.; Dupont, A.; Labrie, F. 1986: Stimulation of the circulating levels of glycoprotein hormone alpha-subunit after combined administration of a luteinizing hormone-releasing hormone (LHRH) agonist and flutamide in patients with cancer of the prostate Clinical and Investigative Medicine. Medecine Clinique et Experimentale 9(4): 215-221
Kawaguchi, T.; Mayama, I.; Iwabuchi, I.; Ogasawara, M.; Tsukui, A. 2010: Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1921-1925
Pai, H.H.; Eldridge, B.; Bishop, D.; Alexander, A.; Lesperance, M.; Blood, P.; Lim, J.; Ludgate, C. 2009: Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy? Canadian Journal of Urology 16(2): 4541-4552
Behrakis, P.; Koutsilieris, M. 1997: Pulmonary metastases in metastatic prostate cancer: host tissue-tumor cell interactions and response to hormone therapy Anticancer Research 17(3a): 1517-1518
Inoue, Y.; Akiyama, M.; Hashine, K.; Sumiyoshi, Y. 1993: Clinical and pathological efficacies of intra-arterial infusion chemotherapy and radiotherapy combined with hormone therapy in prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(11): 1686-1688
Volkov, N.M.; Moiseenko, V.M. 2007: Drug therapy for inoperable gastric cancer: current possibilities and perspectives of development Voprosy Onkologii 53(4): 383-392
Kubota, O.; Onuki, Y.; Uchiyama, T.; Oishi, K.; Takeda, M. 2012: Efficacy of high-dose toremifene as a second-line hormone therapy in patients with advanced or metastatic breast cancer resistant to aromatase inhibitor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(5): 753-757
Shimizu, T.; Shibata, Y.; Uchida, T.; Satoh, J. 1993: Severe flare-up in a prostate cancer patient treated with luteinizing hormone-releasing hormone analogue depot Hinyokika Kiyo. Acta Urologica Japonica 39(10): 953-955